Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
US9132206B2 · kind B2 · utility
30Cited by
105References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 5, 2015 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Jan 5, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2982
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Improved hemostatic agents take the form of granules or particles that can be used to stanch, seal, or stabilize a site of hemorrhage, including a noncompressible hemorrhage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.